Med Life SA

Med Life SA

BBVB:M
11.30
RON
-0.20
(-1.74%)
-0.10EPS
6.30BMarket Cap
Nov 20Next Earn
Med Life SA
BVB:M
(Bucharest Stock Exchange)

Recent

price

11.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
RON
- -
0.81
1.04
1.29
1.49
1.83
2.03
2.69
3.38
4.2
5.11
6.26
Revenue per Share
- -
0.02
-0.01
0.01
0.03
0.03
0.11
0.19
0.06
0.01
0.05
-0.07
Basic EPS, GAAP
- -
0.03
0.02
-0.01
- -
0.1
0.07
0.25
0.03
-0.07
0.05
0.04
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.01
- -
0.01
0.01
- -
- -
- -
- -
Dividend per Share
0.15
0.17
0.17
0.32
0.31
0.36
0.47
0.66
0.82
0.79
0.82
0.86
Book Value per Share
0.08
0.09
0.02
0.11
0.07
0.09
0.09
0.15
-0.1
-0.28
-0.33
-0.37
Tangible Book Value per Share
482
482
482
482
531
529
530
531
531
526
531
531
Basic Weighted Avg Shares
- -
391
503
623
795
967
1,077
1,427
1,795
2,210
2,715
3,323
Sales/Revenue/Turnover
- -
7.42
3.69
5.59
4.83
5.76
11.14
12.41
5.52
4.26
5.58
5.18
Operating Margin (%)
- -
27
36
43
57
90
103
114
152
197
249
302
Depreciation Expense
- -
9
-5
4
13
14
57
103
32
4
26
-36
Net Income, GAAP
- -
23.8
206.23
38.84
29.58
33.19
18.83
16.62
24.47
196.87
58.58
- -
Effective Tax Rate (%)
- -
2.19
-1.02
0.7
1.68
1.41
5.26
7.19
1.79
0.17
0.94
-1.1
Profit Margin (%)
-42
-60
-55
3
-121
-133
-35
-32
-110
-166
-322
-207
Working Capital
157
155
213
253
439
478
562
591
1,028
1,350
1,488
1,805
LT Debt
77
87
93
168
179
207
269
381
482
494
507
525
Total Equity
- -
8.33
-7.01
5.58
4.7
5.19
10.44
14.33
5.25
-4.86
2.76
- -
Return on Invested Capital (%)
- -
5.8
-7.52
2.19
3.77
3.21
7.9
10.74
3.8
-3.35
3.32
- -
Return on Capital (%)
- -
11.12
-6.28
3.75
8.59
7.93
26.66
35.42
8.52
0.89
6.02
-8.09
Return on Common Equity (%)

Capital Structure

RON

•

in mil. unless spec.
Sep'25
Mar'25
Jun'25
ST Debt
210
238
267
LT Borrowings
1,453
1,481
1,503
LT Finance Leases
282
301
302
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
531
531
531
Market Capitalization
4,156
6,232
6,295

Working Capital

RON

•

in mil. unless spec.
Sep'25
Mar'25
Jun'25
Total Current Assets
706
743
770
Cash, Cash Equivalents & STI
185
168
159
Accounts Receivable, Net
159
324
356
Inventories
141
157
161
Total Current Liabilities
863
930
977
Payables & Accruals
- -
- -
- -
ST Debt
210
238
267
Deferred Revenue
- -
- -
- -

Growth Rates

RON

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
22.62%
20.67%
2.65%
Free Cash Flow
- -
-80.14%
-177.15%
Net Income, GAAP
- -
166.75%
593.37%
Sales/Revenue/Turnover
- -
23.12%
22.85%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

RON

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
647
664
668
737
2,715
2025
886
796
788
853
- -

Quarterly Earnings Per Share

RON

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.01
0.01
- -
0.05
2025
-0.07
-0.03
0.01
0.02
- -

Quarterly Dividends Per Share

RON

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Med Life SA is a Romania-based company primarily engaged in the provision of private healthcare and medical services. Founded in 1996 and headquartered in Bucharest, Romania, the company operates one of the largest private medical networks in Central and Eastern Europe, serving both individual retail patients and corporate clients through occupational health and subscription-based medical packages. Med Life operates across seven integrated business segments: Clinics and Outpatient Care, which offers multidisciplinary outpatient consultations, diagnostic examinations, ambulatory care, and day-care medical services across a nationwide network of hyperclinics and medical centers; Hospitals, which provides inpatient medical and surgical care across general, maternity, oncological, and pediatric hospitals equipped with operating theaters, intensive care units, and specialized wards; Laboratories, which conducts diagnostic laboratory testing across regional networks offering clinical biochemistry, hematology, immunology, microbiology, molecular biology, and advanced genetic testing; Corporate, which delivers occupational medicine, preventative health screenings, and customized healthcare subscription plans for corporate employee benefit programs; Pharmacies, which distributes prescription medications, over-the-counter pharmaceuticals, dermato-cosmetics, and medical supplies through its PharmaLife Med pharmacy network; Dental Care, which delivers comprehensive stomatological, orthodontic, implantology, and pediatric dental treatments through specialized dental clinic networks including Dent Estet; and Wellness, which integrates medical rehabilitation, physical therapy, and fitness facilities. The company operates predominantly across Romania, with regional cross-border operations in Hungary through its subsidiary, Rózsakert Medical Center. In recent operational and strategic developments, Med Life has maintained an active consolidation strategy through acquisitions and integrations of regional medical centers, specialized oncology and imaging clinics, and stomatology networks, supported by expanded syndicated credit facilities with major commercial banking syndicates. Additionally, the company has advanced its operational modernization by implementing drone-based transport systems for biological laboratory samples, deploying artificial intelligence-assisted diagnostic imaging tools, enhancing digital telemedicine and patient portal platforms via its proprietary mobile application, and investing in renewable energy infrastructure through the installation of photovoltaic solar panels across its medical facilities.